Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Monti

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Trials|August 2, 2020
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trialOriana Nanni, Pierluigi Viale, Bernadette Vertogen, et al.
Oncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.
Frontiers in Medicine|January 31, 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES StudyManuela Monti, Tom Degenhardt, Etienne Brain, et al.
Cell Stem Cell|October 3, 2009
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factorsAkira Nishiyama, Li Xin, Alexei A Sharov, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Trials|August 2, 2020
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trialOriana Nanni, Pierluigi Viale, Bernadette Vertogen, et al.
Oncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.
Frontiers in Medicine|January 31, 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES StudyManuela Monti, Tom Degenhardt, Etienne Brain, et al.
Cell Stem Cell|October 3, 2009
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factorsAkira Nishiyama, Li Xin, Alexei A Sharov, et al.
Pageof 9